Ingenus Pharms Llc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for INGENUS PHARMS LLC, and what generic alternatives to INGENUS PHARMS LLC drugs are available?
INGENUS PHARMS LLC has eleven approved drugs.
There is one US patent protecting INGENUS PHARMS LLC drugs. There is one tentative approval on INGENUS PHARMS LLC drugs.
There is one patent family member on INGENUS PHARMS LLC drugs in one country and eighteen supplementary protection certificates in eight countries.
Summary for Ingenus Pharms Llc
International Patents: | 1 |
US Patents: | 1 |
Tradenames: | 11 |
Ingredients: | 11 |
NDAs: | 11 |
Drugs and US Patents for Ingenus Pharms Llc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ingenus Pharms Llc | CARMUSTINE | carmustine | INJECTABLE;INJECTION | 211011-001 | Jun 21, 2022 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Ingenus Pharms Llc | MELPHALAN HYDROCHLORIDE | melphalan hydrochloride | INJECTABLE;INJECTION | 210947-001 | Feb 18, 2020 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Ingenus Pharms Llc | CYCLOPHOSPHAMIDE | cyclophosphamide | SOLUTION;INTRAVENOUS | 212501-001 | Jul 30, 2020 | RX | Yes | Yes | 10,993,952 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Ingenus Pharms Llc | ARSENIC TRIOXIDE | arsenic trioxide | INJECTABLE;INJECTION | 209315-001 | Nov 15, 2018 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Ingenus Pharms Llc | CYCLOPHOSPHAMIDE | cyclophosphamide | SOLUTION;INTRAVENOUS | 212501-002 | Jul 30, 2020 | RX | Yes | Yes | 10,993,952 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Ingenus Pharms Llc | CABERGOLINE | cabergoline | TABLET;ORAL | 204735-001 | Aug 1, 2018 | AB | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Ingenus Pharms Llc Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
World Intellectual Property Organization (WIPO) | 2016132270 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Ingenus Pharms Llc Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0227494 | 95C0013 | Belgium | ⤷ Try a Trial | PRODUCT NAME: TIMOLOLI MALEAS EQ. TIMOLOLUM; NATIONAL REGISTRATION/DATE: 922 IS 166 F 13 19950627; FIRST REGISTRATION: SE 11901 19930910 |
0260415 | C990036 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: CARMUSTINE; NAT. REGISTRATION NO/DATE: RVG 24056 19990809; FIRST REGISTRATION: FR 561 907-5 19981210 |
0509752 | 2000C/001 | Belgium | ⤷ Try a Trial | PRODUCT NAME: DORZOLAMIDI HYDROCHLORIDUM EQ. DORZOLAMIDUM, TIMOLOLI MALEAS EQ. TIMOLOLUM; NAT. REGISTRATION NO/DATE: 922 IS 180 F 13 19981110; FIRST REGISTRATION: DK 19045 19980306 |
0166287 | SPC/GB96/056 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: PANTOPRAZOLE AND ITS SALTS, HYDRATES AND HYDRATES OF ITS SALTS; REGISTERED: SE SE12131 19940506; UK 04889/0010 19960604 |
0509752 | C990041 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: DORZOLAMIDE, DESGEWENST IN DE VORM VAN EEN OFTALMOLOGISCH AAN- VAARDBAAR ZOUT, EN TIMOLOL, DESGEWENST IN DE VORM VAN EEN OFTAL -MOLOGISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER DORZOLLAMIDEHY- DROCHLORIDE EN TIMOLOLMALEAAT, EEN EN ANDER ZODANIG DAT 0,05; NATL REGISTRATION NO/DATE: VG 22871 19980805; FIRST REGISTRATION: DK 19045 19980306 |
2701720 | CR 2022 00054 | Denmark | ⤷ Try a Trial | PRODUCT NAME: MELPHALAN FLUFENAMIDE HYDROCHLORIDE; REG. NO/DATE: EU/1/22/1669 20220818 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.